Home Newsletters Ex Vivo Chemosensitivity Assay Using Primary Ovarian Cancer Organoids for Predicting Clinical...

Ex Vivo Chemosensitivity Assay Using Primary Ovarian Cancer Organoids for Predicting Clinical Response and Screening Effective Drugs

0
We prepared organoids using the cancer tissue-originated spheroid method from 61 patients with ovarian cancer. Chemosensitivity assays for paclitaxel and carboplatin were performed using the primary organoids from 50 patients who received the chemotherapy.
[Human Cell]
Abstract
Exit mobile version